Home › Glioblastoma › NCT06989086
FearLess in NeuroOncology
Recruiting
FearLess in Neuro-Oncology
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: Patients: * Self-report a diagnosis of a primary malignant brain tumor (grade II-IV) * \>2 weeks post-cranial resection or biopsy * Elevated Fear of Recurrence Distress Rating * Primarily English speaking * \>/= 18 years of age at the time of enrollment Caregivers: * nonprofessional caregiver to a patient with a primary malignant brain tumor (grade II-IV) * Elevated Fear of Recurrence Distress Rating * Primarily English speaking * \>/= 18 years of age at the time of enrollment Exclusion Criteria: Patient / Caregiver Exclusion: * Cognitive impairment that might prohibit active intervention engagement * Inability to understand and provide informed consent * Inability to attend virtual sessions due to unstable or no internet connection
About the study
The overarching goal of this project is to assess the feasibility, acceptability, and appropriateness of recruitment methods, target population, and a waitlist design to finalize the protocol of FearLess in primary malignant brain tumor patients and caregivers
What is being tested
- Fearless in Neuro-Oncology (behavioral)
Sponsor: Virginia Commonwealth University · Participants: 112 · Started: Jun 24, 2025
Contact the study team
- Mary Bridgman · Phone: 804-628-6799
Official record on ClinicalTrials.gov — NCT06989086
Locations in the U.S.
| Virginia | Virginia Commonwealth University, Richmond |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.